Hiroshi Asahara (Tokyo Medical and Dental University)
Dr. Hiroshi Asahara is a Professor in the Department of Systems BioMedicine at Tokyo Medical and Dental University. After graduating from Okayama University Medical School, he was trained as an Orthopedic Surgeon, and his career as a researcher led him to be a postdoctoral fellow at Harvard Medical School and a staff scientist at Salk Institute, under Prof. Marc Montminy. Dr. Asahara then started his own lab as Assistant Professor at Scripps Research Institute, USA, and then became Department Head at the National Research Institute for Child Health and Development, Japan. At Tokyo Medical and Dental University, he is tasked with the responsibility to construct a new department in the Faculty of Medicine, with the mission to encode the molecular network regulating human development and regeneration by combining multiple post-genomic systems approaches. Based on his unique Systems Biomedicine approaches combining a novel strategy and database, he and his lab are trying to uncover molecular mechanisms of musculoskeletal development and are also identifying the critical pathway to regulate inflammatory diseases, including rheumatoid arthritis.
Kent S. Boles (Synthetic Genomics, Inc.)
Trey Ideker (University of California, San Diego)
Dr. Ideker is a Professor of Medicine at UCSD. He is the Director of the San Diego Center for Systems Biology and the Director of the National Resource for Network Biology. He is a pioneer in using genome-scale measurements to construct network models of cellular processes and disease.
Ross D. King (Manchester University)
Dr. Ross D. King is Professor of Machine Intelligence at the University of Manchester, UK. His main research interests are in the interface between computer science and biology/chemistry. The research achievement he is most proud of is originating the idea of a “Robot Scientist”: using laboratory robotics to physically implement a closed-loop scientific discovery system. His Robot Scientist “Adam” was the first machine to hypothesise and experimentally confirm scientific knowledge. His new robot “Eve” is searching for drugs against neglected tropical diseases. His work on this subject has been published in the top scientific journals, Science and Nature, and has received wide publicity. He is also very interested in NP problems, computational economics, and computational aesthetics.
Masaki Matsumoto (Kyushu University)
Masaki Matsumoto received a Ph.D. degree from the Fukuoka University Graduate School of Science in 1998. He then joined Dr. Keiichi Nakayama lab at the Medical Institute of Bioregulation at Kyushu University as a postdoctoral fellow. He has been appointed at the Kyushu University since 2007. Recently, his group has developed a new targeted proteomics platform—in vitro proteome–assisted MRM for protein absolute quantification (iMPAQT), which is based on genome-wide recombinant protein library and multiple reaction monitoring. Currently he is working on the development of more accurate and reproducible proteomics with “Maholo”.
Tohru Natsume (National Institute of Advanced Industrial Science and Technology)
Dr. Tohru Natsume is the Director of Molecular Profiling Research Center for Drug Discovery at National Institute of Advanced Industrial Science and Technology and Visiting Professor of the Tokyo Metropolitan University. He received a Ph.D. from the Kyoto University Graduate School of Medicine and Faculty of Medicine. He developed a general-purpose experimental robot “Maholo” collaborated with YASKAWA Electric Corporation.
Hideyuki Saya (Keio University)
Hideyuki Saya MD, PhD graduated from Kobe University School of Medicine in 1981 and was Resident in the Neurosurgery until 1983. After which he joined the Graduate School of Medical Sciences gaining his PhD in 1987. He studied as a Postdoctoral Fellow in UCSF until 1988 then was appointed Assistant Professor at the Neuro-Oncology, M.D. Anderson Cancer Center. Houston, TX. From 1994 to 2006 he was Professor, Kumamoto University School of Medicine before taking his current position in Keio University School of Medicine in 2007. He is currently a vice president of Keio University Hospital and Director of Clinical and Translational Research Center. He is interested in basic biology of cancer stem cells and developing new therapeutic approaches for refractory cancers.